Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study.
PHENYTEK®* Capsules (extended phenytoin sodium capsules, USP)
Posturography in MS patients treated with high dose methylprednisolone.
Statement on a nonproprietary name adopted by the USAN Council
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.
Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate.
Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.
Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy.
Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
Effects of dimethyl fumarate on lymphocyte subsets.
A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
Genzyme reports positive top-line results of TOWER, a pivotal phase III trial for AUBAGIO(TM*) (teriflunomide) in relapsing multiple sclerosis
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment.
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.
The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada.
Primary Progressive MS evolving from Radiologically Isolated Syndrome.
American Society for Neurochemistry Annual Meeting
Our Products (page shows "Copaxone" as a trade name for glatiramer acetate)
A Pilot Trial of Interferon beta-1a in Alzheimer's Disease
Flupirtine
Peripheral Bilateral Telangiectasiae in Multiple Sclerosis Patients Treated with Interferon B1a.

Pages